PAST TOP PICK
(A Top Pick July 7/10. Down 10.07%.) Sold his holdings.
biotechnology / pharmaceutical
PAST TOP PICK
(A Top Pick Dec 16/09. Down 14.43%.) Supplies to seniors’ homes. Pays a yield of 9%. Missed their growth objectives so he sold his holdings.
biotechnology / pharmaceutical
WATCH
Distribute healthcare products primarily to retirement homes. Started to see more competition in the 2nd quarter and intensified in the 3rd quarter. Cut distributions once but may do another cut. He’ll wait for Q4 results.
biotechnology / pharmaceutical
COMMENT
Rarely sells after an earnings disappointment. Doesn’t think there is a structural problem with the business. They need to get some clarity on how they will transition into what is in effect a new business model where they will have a growth side.
biotechnology / pharmaceutical
TOP PICK
Distributes supplies such as wound management, chairs, furniture, etc. to retirement homes. Well run. Have already cut their distributions. Trades at 6 times EBITDA.
biotechnology / pharmaceutical
TOP PICK
Conservative name trading at 10-11 times PE. Entrepreneurial management team with ownership in the company. Strong market share in the distribution business in healthcare and long term care facilities.
biotechnology / pharmaceutical
TOP PICK
Distribution services for nursing homes. Generates a lot of free cash flow. Nursing homes are a growing market. Recession resistant. 13% distribution.
biotechnology / pharmaceutical
TOP PICK
Distributor of medical products, mostly in Ontario. Just bought a Quebec company, which should grow revenues and margin expansion. 12% distribution is likely to be increased this year. Earnings per share should grow at 10%-20% also.
biotechnology / pharmaceutical
COMMENT
Sells supplies to nursing homes, which is a growth industry long-term. Good management team.
biotechnology / pharmaceutical
TOP PICK
He supplied provider to hospitals, nursing homes, et cetera. Healthcare sector so very protected in the event of a recession. Growing between 5% and 15% annually. Generates a lot of free cash flow. Distribution of around $.92 giving a 10% yield plus 10% growth.
biotechnology / pharmaceutical
TRADE
It's appropriately priced. A fairly stable business. They do the distribution of medical products.
biotechnology / pharmaceutical
DON'T BUY
Provide diapers/furniture to old age care facilities. Disappointed in some of their early earnings.
biotechnology / pharmaceutical
COMMENT
Sold his holdings. Really like the company because it was health care and not cyclical. Long-term outlook is really great. Good management. Price has dropped and he expects at some time he will own it again. Will look at the next quarter’s results.
biotechnology / pharmaceutical
DON'T BUY
Basically distributes products to the long care sector. A play on the ageing population. 70/75% of its business is very stable. Has performed quite well. Also sells diagnostic equipment, which tends to be volatile. Expensive at the current level.
biotechnology / pharmaceutical
PAST TOP PICK
(A Top Pick Feb 15/06. Up 30%.) A very stable business distributing supplies to retirement homes. A lot of free cash flow.
biotechnology / pharmaceutical
Showing 1 to 15 of 18 entries

Futuremed Healthcare(FMD-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Futuremed Healthcare is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Futuremed Healthcare(FMD-T) Frequently Asked Questions

What is Futuremed Healthcare stock symbol?

Futuremed Healthcare is a OTC stock, trading under the symbol FMD-T on the (). It is usually referred to as or FMD-T

Is Futuremed Healthcare a buy or a sell?

In the last year, there was no coverage of Futuremed Healthcare published on Stockchase.

Is Futuremed Healthcare a good investment or a top pick?

Futuremed Healthcare was recommended as a Top Pick by on . Read the latest stock experts ratings for Futuremed Healthcare.

Why is Futuremed Healthcare stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Futuremed Healthcare worth watching?

0 stock analysts on Stockchase covered Futuremed Healthcare In the last year. It is a trending stock that is worth watching.

What is Futuremed Healthcare stock price?

On , Futuremed Healthcare (FMD-T) stock closed at a price of $.